Because there was a discrepancy in the association between lymph node metastasis and Rad51 expression in the groups with and without NACRT, we also analyzed Rad51 expression and clinicopathological factors, matching the staging of subjects. This evidence concerns the gene RAD51 and metastatic malignant neoplasm in the lymph nodes.